UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060977
Receipt number R000069255
Scientific Title Non-Invasive Diagnosis and Prognostic Modeling Study in Steatotic Liver Disease in JAPAN
Date of disclosure of the study information 2026/03/31
Last modified on 2026/03/18 20:52:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of a Non-Invasive Diagnostic Algorithm and Prognostic Prediction Model for Steatotic Liver Disease in JAPAN:
A Multicenter Retrospective Large-Scale Database Study

Acronym

A Multicenter Study Using Non-Invasive Tests to Predict Long-Term Outcomes in Fatty Liver Disease in JAPAN

Scientific Title

Non-Invasive Diagnosis and Prognostic Modeling Study in Steatotic Liver Disease in JAPAN

Scientific Title:Acronym

SLD-NILDA JAPAN Study

Region

Japan


Condition

Condition

Patients with Steatotic Liver Disease(SLD)

Classification by specialty

Medicine in general Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objective of this study is to establish a large-scale NILDA database in patients with steatotic liver disease (SLD) by integrating patient demographics, laboratory findings, and histopathological assessments. Using this database as a foundation, we aim to comprehensively re-evaluate non-invasive diagnostic algorithms for SLD and to develop prognostic prediction models for overall survival through multifaceted analyses.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Prognosis of Steatotic Liver Disease Using the NILDA Database

Key secondary outcomes

1) To develop predictive models for the progression of liver injury and hepatocarcinogenesis in patients with steatotic liver disease (SLD) using the NILDA database.
2) To evaluate the diagnostic performance of NILDA for liver fibrosis and to determine optimal cutoff values, using liver biopsy and magnetic resonance elastography (MRE) as reference standards.

3) To evaluate the diagnostic performance of NILDA for hepatic steatosis and to determine optimal cutoff values, using liver biopsy and magnetic resonance imaging-proton density fat fraction (MRI-PDFF) as reference standards.

4) To develop a predictive model for identifying patients with high-risk metabolic dysfunction-associated steatohepatitis (MASH), defined as a NAFLD activity score >=4 and liver fibrosis stage >=2.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients diagnosed with SLD or suspected SLD
Definition of suspected SLD: patients meeting at least one of the following criteria
Patients with cardiometabolic risk factors
Patients with liver function abnormalities

Key exclusion criteria

1) Patients deemed ineligible by the attending physician
2) Patients who have declined participation following public disclosure of the study

Target sample size

2000


Research contact person

Name of lead principal investigator

1st name Kuroda
Middle name
Last name Hidekatsu

Organization

Iwate Medical University

Division name

Division of Gastroenterology and Hepatology, Department of Internal Medicine

Zip code

028-3695

Address

2-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, Japan

TEL

019-613-7111

Email

hikuro@iwate-med.ac.jp


Public contact

Name of contact person

1st name Abe
Middle name
Last name Tamami

Organization

Iwate Medical University

Division name

Division of Gastroenterology and Hepatology, Department of Internal Medicine

Zip code

028-3695

Address

2-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, Japan

TEL

019-613-7111

Homepage URL


Email

mokosantokosan@yahoo.co.jp


Sponsor or person

Institute

Iwate Medical University

Institute

Department

Personal name



Funding Source

Organization

Iwate Medical University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of Iwate Medical University

Address

2-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, Japan

Tel

019-613-7111

Email

kenkyu-rinri@j.iwate-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

岩手医科大学


Other administrative information

Date of disclosure of the study information

2026 Year 03 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 02 Month 19 Day

Date of IRB

2025 Year 04 Month 18 Day

Anticipated trial start date

2026 Year 04 Month 01 Day

Last follow-up date

2030 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

N/A


Management information

Registered date

2026 Year 03 Month 18 Day

Last modified on

2026 Year 03 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069255